Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

INOVIQ - Healthcare Conference Investor Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

Immutep - New Patents Granted in Japan and South Korea for Efti (ASX:IMM)

SYDNEY, AUSTRALIA – 9 November 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developin...read more

ImpediMed - AstraZeneca Further Extends Clinical Trial Contract (ASX:IPD)

Key Highlights AstraZeneca extends its contract for a Phase IIb trial, which utilises 210 SOZO® devices to measure fluid volume in patients with chronic kidney disease, for an add...read more

Immutep - Abstract for Efti selected for SITC 2022 Press Conference (ASX:IMM)

SYDNEY, AUSTRALIA – 04 November 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing nov...read more

Immutep - Late Breaking Abstract accepted for SITC Oral Presentation (ASX:IMM)

SYDNEY, AUSTRALIA – 03 November 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developin...read more

Immutep Corporate Presentation (ASX:IMM)

To view the presentation, download the attached PDF.

Immutep to Participate in Two Upcoming Investor Conferences (ASX:IMM)

SYDNEY, AUSTRALIA – 02 November 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developin...read more

Immutep - Annual Report filed on Form 20-F with SEC (ASX:IMM)

To view the annual report, download the attached PDF.

INOVIQ - Appendix 4C & Quarterly Activities Report-September 2022 (ASX:IIQ)

SubB2M-based Surface Plasmon Resonance (SPR) test to be developed with Nicoya on the Alto™ Digital SPR instrument Contract sales force appointed via agreement with P...read more

INOVIQ - Canadian Patent Granted for BARD1 Technology (ASX:IIQ)

Key points: -- Canadian Patent No. 2,929,457 granted covering lung cancer diagnosis -- IP protection in Canada for BARD1 autoantibody test for diagnosis of lung cancer in Canada Melbourne, Au...read more

INOVIQ - Investor Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

INOVIQ - Notice of Annual General Meeting (ASX:IIQ)

Melbourne, Australia, 27 October 2022: INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company) advises that INOVIQ’s 2022 Annual General Meeting (AGM) is to be held at the offices of Grant Thornton, ...read more

Immutep - Independent DMC recommends to continue TACTI-003 as planned (ASX:IMM)

SYDNEY, AUSTRALIA – 26 October 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing...read more

Immutep - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:IMM)

To view the report, download the attached PDF.

Immutep - Notice of Annual General Meeting/Proxy Form (ASX:IMM)

TAKE NOTICE that the 2022 Annual General Meeting of shareholders of Immutep Limited (ACN 009 237 889) will be held at the time and date specified below... For more information, download the attac...read more

Viewing: 181 - 195 of 200 Previous | Next